Multifunctional Nanozymes by Amplifying Intracellular Oxidative Stress for Enhanced Photothermal–Photodynamic Therapy
Source abstract
Abstract
Due to the high efficiency and noninvasive nature, photodynamic therapy (PDT) and photothermal therapy (PTT) have received increasing attention as a potential tumor treatment approach. However, extreme hypoxia and overexpressed glutathione (GSH) in tumor cells restrict therapeutic efficacy. In this contribution, a multifunctional nanozyme of IR780-HCuS@MnO 2 (I/C@M) was synthesized for tumor synergistic PPT and enhanced PDT. In the constructed nanozymes, hollow mesoporous copper sulfide (HCuS) as the core, the near-infrared dye IR780 iodide was loaded for PDT and PTT, and manganese dioxide (MnO 2 ) was coated as a “gatekeeper” to prevent drug leakage on the surface. Under pH stimulation, MnO 2 disintegrated to release IR780, producing exogenous reactive oxygen species (ROS) for PDT after under near-infrared (NIR) irritation. With the assistance of NIR, IR780 and HCuS can be used for PTT, and the double photothermal effect is higher than that of single therapy. In addition, MnO 2 can amplify intracellular oxidative stress by depleting abundant GSH and H 2 O 2 in the tumor, which will further enhance the PDT of IR780. Importantly, three treatments can be performed at the same time with only one laser irradiation. The excellent therapeutic effect of facilitating apoptosis and suppressing tumor growth was generally evaluated and validated both in vivo and in vitro. In summary, our work developed a potential nanomedicine for the synergistic treatment of breast cancer.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Advanced Photocatalysis Techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Gastroenterology of Southwest Hospital Army Medical University, Third Military Medical University, Chongqing 400038, P. R. China
TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610075, P. R. China
College of Chemistry and Chemical Engineering, Linyi University, Linyi 276012, Shandong, P. R. China
Funding
National Natural Science Foundation of China
References (46)
Show source-provided references
1. 10.1158/1078-0432.CCR-17-111710.1158/1078-0432.CCR-17-1117 ↗
2. 10.3390/biomedicines903030510.3390/biomedicines9030305 ↗
3. 10.1016/j.addr.2021.11395410.1016/j.addr.2021.113954 ↗
4. 10.1002/adhm.20190013210.1002/adhm.201900132 ↗
5. 10.1038/s41571-020-0410-210.1038/s41571-020-0410-2 ↗
6. 10.1038/s12276-021-00599-710.1038/s12276-021-00599-7 ↗
7. 10.1021/acsnano.8b0722410.1021/acsnano.8b07224 ↗
8. 10.1039/C7CP00983F10.1039/C7CP00983F ↗
9. 10.1016/j.jconrel.2020.08.01210.1016/j.jconrel.2020.08.012 ↗
10. 10.1038/s41598-021-98638-w10.1038/s41598-021-98638-w ↗
11. 10.1021/acsami.9b2158910.1021/acsami.9b21589 ↗
12. 10.1021/acs.accounts.8b0021410.1021/acs.accounts.8b00214 ↗
13. 10.2147/IJN.S33759910.2147/IJN.S337599 ↗
14. 10.1016/j.jcis.2021.07.09210.1016/j.jcis.2021.07.092 ↗
15. 10.1002/adhm.20190152810.1002/adhm.201901528 ↗
16. 10.1021/acsnano.8b0504210.1021/acsnano.8b05042 ↗
17. 10.1002/anie.20171202710.1002/anie.201712027 ↗
18. 10.1016/j.jconrel.2021.08.02210.1016/j.jconrel.2021.08.022 ↗
19. 10.1021/acs.langmuir.8b0047410.1021/acs.langmuir.8b00474 ↗
20. 10.1021/acsami.8b0721310.1021/acsami.8b07213 ↗
21. 10.1002/advs.20220000510.1002/advs.202200005 ↗
22. 10.1016/j.jcis.2021.03.17310.1016/j.jcis.2021.03.173 ↗
23. 10.1016/j.actbio.2021.03.02410.1016/j.actbio.2021.03.024 ↗
24. 10.1016/j.ijbiomac.2022.11.01910.1016/j.ijbiomac.2022.11.019 ↗
25. 10.1038/s41368-021-00132-610.1038/s41368-021-00132-6 ↗
26. 10.1021/acsnano.8b0203410.1021/acsnano.8b02034 ↗
27. 10.34133/2021/986138410.34133/2021/9861384 ↗
28. 10.1016/j.bioactmat.2021.04.00410.1016/j.bioactmat.2021.04.004 ↗
29. 10.1021/acsnano.1c0955510.1021/acsnano.1c09555 ↗
30. 10.1002/adma.20180180810.1002/adma.201801808 ↗
31. 10.1016/j.biomaterials.2023.12225710.1016/j.biomaterials.2023.122257 ↗
32. 10.1016/j.biomaterials.2021.12103510.1016/j.biomaterials.2021.121035 ↗
33. 10.1016/j.jconrel.2020.12.04810.1016/j.jconrel.2020.12.048 ↗
34. 10.1016/j.ijpharm.2018.03.02010.1016/j.ijpharm.2018.03.020 ↗
35. 10.7150/thno.4029110.7150/thno.40291 ↗
36. 10.1002/adhm.20230094510.1002/adhm.202300945 ↗
37. 10.1002/adhm.20220161510.1002/adhm.202201615 ↗
38. 10.1016/j.mrgentox.2010.01.01410.1016/j.mrgentox.2010.01.014 ↗
39. 10.1039/C6CS00592F10.1039/C6CS00592F ↗
40. 10.1016/j.cej.2023.14136910.1016/j.cej.2023.141369 ↗
41. 10.1016/j.nantod.2023.10189610.1016/j.nantod.2023.101896 ↗
42. 10.3390/biom1010142910.3390/biom10101429 ↗
43. 10.1002/smtd.20210153110.1002/smtd.202101531 ↗
44. 10.1021/acsnano.0c0308010.1021/acsnano.0c03080 ↗
45. 10.1002/advs.20200367910.1002/advs.202003679 ↗
46. 10.1021/acsnano.7b0810310.1021/acsnano.7b08103 ↗